Disclosed are compounds having the ability to inhibit cytochrome P450 2A6, 2A13, and/or 2B6 and tobacco products comprising them. Also disclosed are pharmaceutical compositions comprising them.
The present invention provides a fragrance precursor of formula I:
1
that is capable of forming a fragrant ketone of formula II:
2
and a fragrant lactone of formula III:
3
The compounds of the formula I
are precursors for organoleptic and antimicrobial compounds. The latter are generated in the presence of skin bacteria, enzymes or acidic or alkaline conditions. One precursor molecule can provide one or more different compounds.
式 I 的化合物
是感官和抗菌化合物的前体。后者在皮肤细菌、酶或酸性或碱性条件下生成。一个前体分子可以提供一种或多种不同的化合物。
Precursor Compounds
申请人:GIVAUDAN-ROURE (INTERNATIONAL) SA
公开号:EP0887336A1
公开(公告)日:1998-12-30
The compounds of the formula I
are precursors for organoleptic and antimicrobial compounds. The latter are generated in the presence of skin bacteria, enzymes or acidic or alkaline conditions. One precursor molecule can provide one or more different compounds.
式 I 的化合物
是感官和抗菌化合物的前体。后者在皮肤细菌、酶或酸性或碱性条件下生成。一个前体分子可以提供一种或多种不同的化合物。
Beta-ketoester
申请人:Givaudan Roure (International) S.A.
公开号:EP0911315A1
公开(公告)日:1999-04-28
The beta-keto esters of formula I are useful for the delivery of organoleptic compounds, especially for flavours, fragrances and masking agents and antimicrobial compounds.